Search - tctmd.com

Displaying 1 - 6 of 6

Sort: Relevancy | Date

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Scaffold in Patients with Coronary Artery Disease (FUTURE-I) 3-Year Clinical and Imaging Outcomes

Presentation CIT 2019

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Scaffold in Patients with Coronary Artery Disease (FUTURE-I) 3-Year Clinical and Imaging Outcomes

Presenter: Bo Xu

March 29, 2019

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Presentation CIT 2019

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Presenter: Yaling Han

March 28, 2019

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease (FUTURE-I): Two-Year Clinical and Imaging Outcomes

Presentation CIT 2018

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease (FUTURE-I): Two-Year Clinical and Imaging Outcomes

Presenter: Bo Xu

March 23, 2018

Session V: Bioabsorbable scaffold - Will this be the default therapy of the next decade? Bifurcation lesions

Presentation CIT 2014

Session V: Bioabsorbable scaffold - Will this be the default therapy of the next decade? Bifurcation lesions

Presenter: Antonio Colombo

March 20, 2014

Science Behind Bioresorbable Vascular Scaffolds

Presentation CIT 2014

Science Behind Bioresorbable Vascular Scaffolds

Presenter: Renu Virmani

March 20, 2014

Clinical Outcomes with BRS in Long Lesions and Overlapping Scaffolds

Presentation CIT 2014

Clinical Outcomes with BRS in Long Lesions and Overlapping Scaffolds

Presenter: P.C. Smits

March 20, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.